Literature DB >> 2316458

Comparison of proximal left anterior descending and circumflex coronary artery dimensions in aortic valve stenosis and hypertrophic cardiomyopathy.

B P Kimball1, V LiPreti, S Bui, E D Wigle.   

Abstract

To examine the "adequacy" of basal coronary flow in ventricular hypertrophy, the relation between proximal coronary artery dimensions and regional ventricular mass in aortic valve stenosis (AS) and hypertrophic cardiomyopathy (HC) was evaluated. Coronary artery size was determined by quantitative coronary arteriography while global/regional ventricular mass was calculated using computer-processed biplane 2-dimensional echocardiography. In comparison to 18 "normal" subjects, left anterior descending coronary dimensions were significantly larger in those with hypertrophy (normal 3.32 +/- 0.54, AS 3.82 +/- 0.71, HC 4.72 +/- 0.81 mm, p less than 0.05), with progressive increases in left anterior descending/circumflex coronary diameter ratios (normal 1.04 +/- 0.14, AS 1.18 +/- 0.19, HC 1.25 +/- 0.31, p less than 0.01). Compared to the AS group, indexed anteroseptal mass was greater in the HC subjects (AS 40.9 +/- 8.9 vs HC 72.1 +/- 21 g/m2, p less than 0.001). Both septal width/left anterior descending coronary diameter ratios (AS 3.61 +/- 1.06 vs HC 4.85 +/- 1.17 mm/mm, p less than 0.05) and indexed anteroseptal mass/left anterior descending coronary diameter ratios (AS 11.2 +/- 3.0 vs HC 15.6 +/- 3.4 g/m2/mm, p less than 0.01) were greater in HC subjects. Increased coronary dimensions were observed in both AS and HC, with the greatest changes noted within the left anterior descending distribution in HC, but when analyzed with respect to regional ventricular mass, these subjects demonstrated relative "inadequate" enlargement in coronary artery diameters. Underdeveloped epicardial coronary arteries may contribute to anteroseptal myocardial ischemia, with resultant angina pectoris, increased ventricular ectopic activity and sudden death in HC.

Entities:  

Mesh:

Year:  1990        PMID: 2316458     DOI: 10.1016/0002-9149(90)91385-j

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Coronary artery-left ventricular shunt: an important cause of chest pain in patients with hypertrophic cardiomyopathy.

Authors:  Mareomi Hamada; Akiyoshi Ogimoto; Kiyotaka Ohshima; Shigehiro Miyazaki; Norio Kubota; Shuntarto Ikeda; Yuji Shigematsu
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

3.  Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  P Petkow Dimitrow; M Krzanowski; R Nizankowski; A Szczeklik; J S Dubiel
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

4.  Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.

Authors:  Ian Leonard Phillip Beales; Abigail Hensley; Yoon Loke
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-08-06

5.  Protective Effect of Aortic Stenosis on the Coronary Arteries. Hypothetic Considerations to an Old Enigma.

Authors:  Paulo Roberto Barbosa Evora; Livia Arcêncio; Alfredo José Rodrigues; André Schmidt
Journal:  Arq Bras Cardiol       Date:  2016-04       Impact factor: 2.000

6.  Coronary fractional flow reserve measurements of a stenosed side branch: a computational study investigating the influence of the bifurcation angle.

Authors:  Claudio Chiastra; Francesco Iannaccone; Maik J Grundeken; Frank J H Gijsen; Patrick Segers; Matthieu De Beule; Patrick W Serruys; Joanna J Wykrzykowska; Antonius F W van der Steen; Jolanda J Wentzel
Journal:  Biomed Eng Online       Date:  2016-08-05       Impact factor: 2.819

7.  Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy.

Authors:  Mareomi Hamada; Yuji Shigematsu; Shuntaro Ikeda; Kiyotaka Ohshima; Akiyoshi Ogimoto
Journal:  ESC Heart Fail       Date:  2021-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.